Zurück zur Auswahl
60033-01 - Vorlesung: Special Topics in Drug Discovery and Development (2 KP)
| Semester | Herbstsemester 2026 |
| Angebotsmuster | Jedes Herbstsemester |
| Dozierende |
Tobias Junt (tobias.junt@unibas.ch)
Stephan Krähenbühl (stephan.kraehenbuehl@unibas.ch) Alex Odermatt (alex.odermatt@unibas.ch) Gisbert Weckbecker (gisbert.weckbecker@unibas.ch, BeurteilerIn) |
| Inhalt | Disease-based molecular knowledge as prerequisite for identifying novel medications in preclinical and clinical settings (cf lecture content on ADAM, Special Topics DDD) Start-ups, big pharma and academic research as drivers of innovative drug-based therapies AI as potential game-changer in pharmaceutical sciences Natural compounds as starting points for efficacious therapies Peptidic drugs as highly potent endocrine modulators Digital platforms and novel analytical procedures enhancing the potential of biomarkers Antifungal approaches and their limiting adverse effects New developments e.g. in the treatment of Alzheimer's Role of drug agencies in drug development |
| Lernziele | Learn from current drug research activities in start-ups, big pharma and academic research |
| Literatur | For details and literature see ADAM |
| Bemerkungen | 100% attendance is compulsory. |
| Weblink | Department of Pharmaceutical Sciences |
| Teilnahmevoraussetzungen | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch |
| Anmeldung zur Lehrveranstaltung | This course is mandatory for Master Drug Sciences students. Students from other programs (Master level or higher) may be admitted if there are free seats. Please contact studienkoordination-pharma@unibas.ch 100% attendance is compulsory. |
| Unterrichtssprache | Englisch |
| Einsatz digitaler Medien | kein spezifischer Einsatz |
| Intervall | Wochentag | Zeit | Raum |
|---|---|---|---|
| wöchentlich | Montag | 10.15-12.00 | Biozentrum, Seminarraum U1.191 |
Einzeltermine
| Datum | Zeit | Raum |
|---|---|---|
| Montag 14.09.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 21.09.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 28.09.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 05.10.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 12.10.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 19.10.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 26.10.2026 | 10.15-12.00 Uhr | Lecture break: examination week |
| Montag 02.11.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 09.11.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 16.11.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 23.11.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 30.11.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 07.12.2026 | 10.15-12.00 Uhr | Biozentrum, Seminarraum U1.191 |
| Montag 14.12.2026 | 10.15-12.00 Uhr | Lecture break: examination week |
| Module |
Doktorat Pharmazeutische Wissenschaften: Empfehlungen (Promotionsfach: Pharmazeutische Wissenschaften) Doktorat Toxikologie: Empfehlungen (Promotionsfach: Toxikologie) Modul: Clinical Drug Development: the Basis for Market Approval (Masterstudium: Drug Sciences) Modul: Vertiefung Medizinische Nanowissenschaften (Masterstudium: Nanowissenschaften) Wahlbereich Master Pharmazie: Empfehlungen (Masterstudium: Pharmazie) |
| Prüfung | Lehrveranst.-begleitend |
| Hinweise zur Prüfung | 100% attendance is compulsory and presentations by all students. More details will be communicated during the first lecture. |
| An-/Abmeldung zur Prüfung | Anm.: Belegen Lehrveranstaltung; Abm.: stornieren |
| Wiederholungsprüfung | keine Wiederholungsprüfung |
| Skala | Pass / Fail |
| Belegen bei Nichtbestehen | beliebig wiederholbar |
| Zuständige Fakultät | Philosophisch-Naturwissenschaftliche Fakultät, studiendekanat-philnat@unibas.ch |
| Anbietende Organisationseinheit | Departement Pharmazeutische Wissenschaften |